Francisco Diaz-Mitoma
2021
In 2021, Francisco Diaz-Mitoma earned a total compensation of $1.9M as Chief Medical Officer at VBI Vaccines, a 52% increase compared to previous year.
Compensation breakdown
| Bonus | $211,779 |
|---|---|
| Option Awards | $1,205,000 |
| Salary | $440,308 |
| Total | $1,857,087 |
Diaz-Mitoma received $1.2M in option awards, accounting for 65% of the total pay in 2021.
Diaz-Mitoma also received $211.8K in bonus and $440.3K in salary.
Rankings
In 2021, Francisco Diaz-Mitoma's compensation ranked 6,335th out of 12,406 executives tracked by ExecPay. In other words, Diaz-Mitoma earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,335 out of 12,406 | 49th |
Division Manufacturing | 2,696 out of 5,492 | 51st |
Major group Chemicals And Allied Products | 1,183 out of 2,368 | 50th |
Industry group Drugs | 1,053 out of 2,089 | 50th |
Industry Pharmaceutical Preparations | 763 out of 1,536 | 50th |
Source: SEC filing on April 29, 2022.
Diaz-Mitoma's colleagues
We found two more compensation records of executives who worked with Francisco Diaz-Mitoma at VBI Vaccines in 2021.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019